Bristol-Myers Squibb 1Q Revenues: $4.0 billion (+4%) 1Q Earnings: $1.2 billion (+27%) Comments: U.S. revenues were up 16% to $2.0 billion in the quarter. International revenues decreased 2% to $2.0 billion. Eliquis sales were $355 million, up from $106 million in 1Q14. Yervoy sales were up 20% to $325 million. Orencia and Sprycel grew 10% to $400 million and $375 million, respectively. Daklinza and Sunvepra had combined sales of $264 million and Opdivo had sales of $40 million. R&D expens...